FGFR3-autoantibodies are not simple biomarkers.
We demonstrate a mechanism via extraceullar binding of autoantibodies to FGFR3 and how to block it.
We think targeting FGFR3 autoantibodies is a new therapeutic entry point for autoimmune neuropathies.
#Therapeutics #AutoimmunePain
We demonstrate a mechanism via extraceullar binding of autoantibodies to FGFR3 and how to block it.
We think targeting FGFR3 autoantibodies is a new therapeutic entry point for autoimmune neuropathies.
#Therapeutics #AutoimmunePain
October 9, 2025 at 5:05 PM
FGFR3-autoantibodies are not simple biomarkers.
We demonstrate a mechanism via extraceullar binding of autoantibodies to FGFR3 and how to block it.
We think targeting FGFR3 autoantibodies is a new therapeutic entry point for autoimmune neuropathies.
#Therapeutics #AutoimmunePain
We demonstrate a mechanism via extraceullar binding of autoantibodies to FGFR3 and how to block it.
We think targeting FGFR3 autoantibodies is a new therapeutic entry point for autoimmune neuropathies.
#Therapeutics #AutoimmunePain
Just remembered with these bitter cold temps why I don't like bitter cold temps.
#HashimotoThyroiditis
#AutoimmunePain
#HashimotoThyroiditis
#AutoimmunePain
January 8, 2025 at 5:11 AM
Just remembered with these bitter cold temps why I don't like bitter cold temps.
#HashimotoThyroiditis
#AutoimmunePain
#HashimotoThyroiditis
#AutoimmunePain